166 related articles for article (PubMed ID: 31484399)
21. Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: a meta-analysis.
Liu H; Zhang QD; Li ZH; Zhang QQ; Lu LG
World J Gastroenterol; 2014 Dec; 20(47):18001-12. PubMed ID: 25548500
[TBL] [Abstract][Full Text] [Related]
22. Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.
Ojima H; Yoshikawa D; Ino Y; Shimizu H; Miyamoto M; Kokubu A; Hiraoka N; Morofuji N; Kondo T; Onaya H; Okusaka T; Shimada K; Sakamoto Y; Esaki M; Nara S; Kosuge T; Hirohashi S; Kanai Y; Shibata T
Cancer Sci; 2010 Apr; 101(4):882-8. PubMed ID: 20088962
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.
Suzuki Y; Kan M; Kimura G; Umemoto K; Watanabe K; Sasaki M; Takahashi H; Hashimoto Y; Imaoka H; Ohno I; Mitsunaga S; Ikeda M
J Gastroenterol; 2019 Mar; 54(3):281-290. PubMed ID: 30298469
[TBL] [Abstract][Full Text] [Related]
24. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.
Okusaka T; Nakachi K; Fukutomi A; Mizuno N; Ohkawa S; Funakoshi A; Nagino M; Kondo S; Nagaoka S; Funai J; Koshiji M; Nambu Y; Furuse J; Miyazaki M; Nimura Y
Br J Cancer; 2010 Aug; 103(4):469-74. PubMed ID: 20628385
[TBL] [Abstract][Full Text] [Related]
25. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
[TBL] [Abstract][Full Text] [Related]
26. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
[TBL] [Abstract][Full Text] [Related]
27. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.
Croitoru A; Gramaticu I; Dinu I; Gheorghe L; Alexandrescu S; Buica F; Luca I; Becheanu G; Herlea V; Simionov I; Hrehoret D; Lupescu I; Popescu I; Diculescu M
J Gastrointestin Liver Dis; 2012 Sep; 21(3):277-84. PubMed ID: 23012669
[TBL] [Abstract][Full Text] [Related]
28. Experimental study of combination therapy with S-1 against pancreatic cancer.
Yoshizawa J; Takizawa A; Takeuchi O; Hiraku O; Sasaki K; Morimoto Y; Atsuda K; Inoue G; Suzuki Y; Asanuma F; Yamada Y
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1211-9. PubMed ID: 19337733
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of synergism between gemcitabine and cisplatin.
van Moorsel CJ; Veerman G; Vermorken JB; Voorn DA; Kroep JR; Bergman AM; Pinedo HM; Peters GJ
Adv Exp Med Biol; 1998; 431():581-5. PubMed ID: 9598132
[No Abstract] [Full Text] [Related]
30. Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
Kim J; Kim H; Lee JC; Kim JW; Paik WH; Lee SH; Hwang JH; Ryu JK; Kim YT
PLoS One; 2018; 13(12):e0209104. PubMed ID: 30557411
[TBL] [Abstract][Full Text] [Related]
31. The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.
Nam HJ; Kim HP; Yoon YK; Song SH; Min AR; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Invest New Drugs; 2012 Dec; 30(6):2148-60. PubMed ID: 22197904
[TBL] [Abstract][Full Text] [Related]
32. Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy.
McHugh LA; Kriajevska M; Mellon JK; Griffiths TR
Urology; 2007 Feb; 69(2):390-4. PubMed ID: 17320695
[TBL] [Abstract][Full Text] [Related]
33. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
[TBL] [Abstract][Full Text] [Related]
34. A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer.
Suzuki E; Ikeda M; Okusaka T; Nakamori S; Ohkawa S; Nagakawa T; Boku N; Yanagimoto H; Sato T; Furuse J
Cancer Chemother Pharmacol; 2013 May; 71(5):1141-6. PubMed ID: 23525694
[TBL] [Abstract][Full Text] [Related]
35. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
Colucci G; Giuliani F; Gebbia V; Biglietto M; Rabitti P; Uomo G; Cigolari S; Testa A; Maiello E; Lopez M
Cancer; 2002 Feb; 94(4):902-10. PubMed ID: 11920457
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.
Mayr C; Neureiter D; Pichler M; Berr F; Wagner A; Kiesslich T; Namberger K
Mol Med Rep; 2015 Aug; 12(2):2247-52. PubMed ID: 25846744
[TBL] [Abstract][Full Text] [Related]
38. Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells.
Georgieva MC; Konstantinov SM; Topashka-Ancheva M; Berger MR
Cancer Lett; 2002 Aug; 182(2):163-74. PubMed ID: 12048162
[TBL] [Abstract][Full Text] [Related]
39. Micelle-contained and PEGylated hybrid liposomes of combined gemcitabine and cisplatin delivery for enhancing antitumor activity.
Liu Z; Chu W; Sun Q; Zhao L; Tan X; Zhang Y; Yin T; He H; Gou J; Tang X
Int J Pharm; 2021 Jun; 602():120619. PubMed ID: 33887396
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital: a retrospective analysis.
Wu CE; Hsu HC; Shen WC; Lin YC; Wang HM; Chang JW; Chen JS
Chang Gung Med J; 2012; 35(5):420-7. PubMed ID: 23127347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
